Medibank Private (Germany) Performance
MPV Stock | EUR 2.24 0.02 0.88% |
Medibank Private has a performance score of 1 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.36, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Medibank Private's returns are expected to increase less than the market. However, during the bear market, the loss of holding Medibank Private is expected to be smaller as well. Medibank Private right now secures a risk of 1.19%. Please verify Medibank Private Limited standard deviation, maximum drawdown, kurtosis, as well as the relationship between the total risk alpha and potential upside , to decide if Medibank Private Limited will be following its current price movements.
Risk-Adjusted Performance
1 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Medibank Private Limited are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Medibank Private is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Begin Period Cash Flow | 671.7 M | |
Total Cashflows From Investing Activities | -623.6 M |
Medibank |
Medibank Private Relative Risk vs. Return Landscape
If you would invest 222.00 in Medibank Private Limited on September 15, 2024 and sell it today you would earn a total of 2.00 from holding Medibank Private Limited or generate 0.9% return on investment over 90 days. Medibank Private Limited is currently producing 0.0208% returns and takes up 1.1893% volatility of returns over 90 trading days. Put another way, 10% of traded stocks are less volatile than Medibank, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
Risk |
Medibank Private Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medibank Private's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Medibank Private Limited, and traders can use it to determine the average amount a Medibank Private's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0175
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | MPV |
Estimated Market Risk
1.19 actual daily | 10 90% of assets are more volatile |
Expected Return
0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Medibank Private is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Medibank Private by adding it to a well-diversified portfolio.
Medibank Private Fundamentals Growth
Medibank Stock prices reflect investors' perceptions of the future prospects and financial health of Medibank Private, and Medibank Private fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Medibank Stock performance.
Return On Equity | 0.21 | |||
Return On Asset | 0.0906 | |||
Profit Margin | 0.06 % | |||
Operating Margin | 0.08 % | |||
Current Valuation | 4.91 B | |||
Shares Outstanding | 2.75 B | |||
Price To Earning | 18.36 X | |||
Price To Book | 4.14 X | |||
Price To Sales | 0.71 X | |||
Revenue | 7.09 B | |||
EBITDA | 574.9 M | |||
Cash And Equivalents | 1.83 B | |||
Cash Per Share | 0.66 X | |||
Book Value Per Share | 0.72 X | |||
Cash Flow From Operations | 948.5 M | |||
Earnings Per Share | 0.09 X | |||
Total Asset | 4.55 B | |||
About Medibank Private Performance
By analyzing Medibank Private's fundamental ratios, stakeholders can gain valuable insights into Medibank Private's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Medibank Private has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Medibank Private has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Medibank Private Limited, an integrated healthcare company, provides private health insurance and health solutions in Australia. Medibank Private Limited was founded in 1976 and is based in Docklands, Australia. MEDIBANK PRIVATE operates under Insurance - Diversified classification in Germany and is traded on Frankfurt Stock Exchange. It employs 3450 people.Things to note about Medibank Private performance evaluation
Checking the ongoing alerts about Medibank Private for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Medibank Private help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Evaluating Medibank Private's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Medibank Private's stock performance include:- Analyzing Medibank Private's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Medibank Private's stock is overvalued or undervalued compared to its peers.
- Examining Medibank Private's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Medibank Private's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Medibank Private's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Medibank Private's stock. These opinions can provide insight into Medibank Private's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Medibank Stock analysis
When running Medibank Private's price analysis, check to measure Medibank Private's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medibank Private is operating at the current time. Most of Medibank Private's value examination focuses on studying past and present price action to predict the probability of Medibank Private's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medibank Private's price. Additionally, you may evaluate how the addition of Medibank Private to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |